Company

News

digital safety vigilance

News, events, updates, and more.

Find out about the latest developments and changes happening at iVigee here.


data network connection points

Jan Petracek at PV Training

Calling all PV professionals, QPPVs, regulators, and auditors!

23.05.2024
data network connections

Jana Hyankova chairing International QA Conference

Our PV team has been busy this spring!

20.05.2024

Jan Petracek speaking at EUFEPS Annual Meeting 2024

Pharmacovigilance Transformation...find out what is changing and what will stay at the 2024 European Federation for Pharmaceutical Sciences (EUFEPS) annual meeting.

15.05.2024

New starter: Lucia Matejkinova

We're thrilled to announce that Lucia Matejkinova joined iVigee as our new QPPV Office Lead on March 1, 2024! She oversees the management of our QPPV office and serves as the EU QPPV for our clients.

09.05.2024
digital safety vigilance

April Regulatory Intelligence News!

Are you aware of the recent update from Swissmedic?

07.05.2024

The results are in!

We asked about the maturity of your regulatory intelligence process

06.05.2024
data cloud network

67th EPSA General Assembly

🌍 Exciting News! We're participating in the upcoming 67th EPSA (European Pharmaceutical Students’ Association) General Assembly today in Prague.

02.05.2024

Pharmacovigilance Regulatory Intelligence Process

How mature is your regulatory intelligence process? 📶

01.05.2024

News from Belgium in iViReg

iViReg leverages hundreds of local experts in 90+ countries to provide interpretations and impact assessments of regulatory changes.

30.04.2024
digital safety vigilance

Contact us about our technology and services.

Whatever your pharmacovigilance requirements, our world-leading technology platforms and globally experienced operational teams can provide the solution.

Email us at info@ivigee.com or fill in and submit the form below.

Our Business Development team will respond within one working day.

Select files to upload
By submitting you agree to our privacy policy.